Status and phase
Conditions
Treatments
About
Evaluation of the effect of H. pylori eradication on regression of H. pylori-related gastric polyp (Ranomized controlled trial)
Study design: open labeled RCT
Study group H. pylori eradication group (N=17), non-eradication group (N=15)
Treatment plan
Baseline EGD
: 0.3-1cm sized polyp - bx & CLO test (antrum & body)
==> if H. pylori positive and eligible patients, randomization
Triple therapy
UBT (4week after eradication)
Follow-up EGD: gross finding, CLO test
Evaluation of polyp regression
Full description
(A) Study population
(B) Study method
Study design: open labeled RCT
Study group H. pylori eradication group (N=17), non-eradication group (N=15)
Treatment plan
Evaluation of polyp regression
Statistical analysis
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
32 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal